BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17996387)

  • 1. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
    Schwarz JK; Siegel BA; Dehdashti F; Myerson RJ; Fleshman JW; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):180-6. PubMed ID: 17996387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of
    Houard C; Pinaquy JB; Mesguich C; Henriques de Figueiredo B; Cazeau AL; Allard JB; Laharie H; Bordenave L; Fernandez P; Vendrely V
    J Nucl Med; 2017 Sep; 58(9):1414-1420. PubMed ID: 28280225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
    Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA
    Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.
    Deantonio L; Milia ME; Cena T; Sacchetti G; Perotti C; Brambilla M; Turri L; Krengli M
    Radiol Med; 2016 Jan; 121(1):54-9. PubMed ID: 26126968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
    Day FL; Link E; Ngan S; Leong T; Moodie K; Lynch C; Michael M; Winton Ed; Hogg A; Hicks RJ; Heriot A
    Br J Cancer; 2011 Aug; 105(4):498-504. PubMed ID: 21792197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma.
    Goldman KE; White EC; Rao AR; Kaptein JS; Lien WW
    Pract Radiat Oncol; 2016; 6(5):e149-e154. PubMed ID: 26948134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET-CT fusion in radiation management of patients with anorectal tumors.
    Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
    Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
    JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
    Gauthé M; Richard-Molard M; Fayard J; Alberini JL; Cacheux W; Lièvre A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):63-70. PubMed ID: 27503193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
    Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.
    Kidd EA; Dehdashti F; Siegel BA; Grigsby PW
    Radiother Oncol; 2010 Jun; 95(3):288-91. PubMed ID: 20231040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome.
    Yeung JM; Kalff V; Hicks RJ; Drummond E; Link E; Taouk Y; Michael M; Ngan S; Lynch AC; Heriot AG
    Dis Colon Rectum; 2011 May; 54(5):518-25. PubMed ID: 21471751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
    Grigsby PW; Siegel BA; Dehdashti F; Rader J; Zoberi I
    J Clin Oncol; 2004 Jun; 22(11):2167-71. PubMed ID: 15169804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.
    Xue F; Lin LL; Dehdashti F; Miller TR; Siegel BA; Grigsby PW
    Gynecol Oncol; 2006 Apr; 101(1):147-51. PubMed ID: 16263155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
    Siva S; Herschtal A; Thomas JM; Bernshaw DM; Gill S; Hicks RJ; Narayan K
    Cancer; 2011 Sep; 117(17):3981-8. PubMed ID: 21365626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
    Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
    Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.